Analyst Price Targets — PRGO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 6, 2025 1:46 pm | — | Canaccord Genuity | $20.00 | $14.73 | TheFly | Perrigo price target lowered to $20 from $40 at Canaccord |
| October 27, 2025 11:40 am | Keith Devas | Jefferies | $23.00 | $21.59 | TheFly | Perrigo price target lowered to $23 from $27 at Jefferies |
| August 7, 2025 1:24 pm | Susan Anderson | Canaccord Genuity | $40.00 | $22.83 | TheFly | Perrigo price target lowered to $40 from $42 at Canaccord |
| September 23, 2024 4:34 pm | Keith Devas | Jefferies | $30.00 | $27.06 | StreetInsider | Jefferies Assumes Perrigo Co. (PRGO) at Hold |
| June 13, 2024 7:36 am | Korinne Wolmeyer | Piper Sandler | $36.00 | $27.84 | StreetInsider | Perrigo Co. (PRGO) PT Lowered to $36 at Piper Sandler |
| April 8, 2024 7:01 am | Korinne Wolmeyer | Piper Sandler | $39.00 | $31.40 | StreetInsider | Perrigo Co. (PRGO) PT Raised to $39 at Piper Sandler, 'We continue to favor PRGO within our Personal Care coverage' |
| November 17, 2023 2:54 pm | Korinne Wolfmeyer | Piper Sandler | $37.00 | $30.07 | Benzinga | Personal Care Industry Poised For Growth: Analyst Initiates Coverage On These 3 Stocks |
| September 6, 2022 5:17 am | Jacob Hughes | Wells Fargo | $54.00 | $36.74 | TheFly | Perrigo upgraded to Overweight from Equal Weight at Wells Fargo |
| May 4, 2022 8:45 am | — | Raymond James | $48.00 | $32.76 | Benzinga | Raymond James Maintains Outperform on Perrigo, Lowers Price Target to $48 |
Latest News for PRGO
DUBLIN, Aug. 27, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to participate in investor meetings at the Barclays Global Consumer Conference on Thursday, September 10th, 2026. About Perrigo Perrigo Company plc is a leading pure-play self-care company…
Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
I present my August top 5 dividend picks: PRGO, MZTI, NEE, TROW, and VICI, all rated Buy or Strong Buy for rising income and appreciation. Each pick trades at a significant discount to fair value (average 21.5%), offering an expected 5-year compound annual total return of ~12.5% and a 5.22% yield. PRGO, MZTI, and VICI stand out for deep undervaluation and robust dividend growth, with VICI offering a projected 15.8%…
Perrigo Company remains substantially undervalued, with a Buy rating justified by strong income and growth potential. Recent quarterly EPS and revenue beats, coupled with market share gains, signal improving fundamentals despite a soft OTC market. Management's focus on cost control, debt reduction, and dividend growth underpins a compelling 16–21% expected annual total return.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.